肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2019 ESMO共识会议建议：局部黑色素瘤的治疗

2020-07-22 欧洲肿瘤内科学会 Ann Oncol . 2020 Jul 22;

黑色素瘤

2019年9月，欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对局部黑色素瘤的治疗的管理提供指导建议。

中文标题：

2019 ESMO共识会议建议：局部黑色素瘤的治疗

英文标题：

ESMO consensus conference recommendations on the management of locoregional melanoma: the ESMO Guidelines Committee

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-07-22

简要介绍：

2019年9月，欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对局部黑色素瘤的治疗的管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESMO共识会议建议：局部黑色素瘤的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f12551c001966089, title=2019 ESMO共识会议建议：局部黑色素瘤的治疗 , enTitle=ESMO consensus conference recommendations on the management of locoregional melanoma: the ESMO Guidelines Committee, guiderFrom=Ann Oncol . 2020 Jul 22;, authorId=0, author=, summary=2019年9月，欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对局部黑色素瘤的治疗的管理提供指导建议。, cover=https://img.medsci.cn/202098/1599495518747_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Wed Jul 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">2019年9月，欧洲肿瘤内科学会(ESMO)召开了黑色素瘤共识会议，本次会议的主要目的是针对ESMO未涵盖的主题制定指导建议，本文主要针对局部黑色素瘤的治疗的管理提供指导建议。</span></p> </div> </div> </div>, tagList=[TagDto(tagId=273, tagName=黑色素瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=273, guiderKeyword=黑色素瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2515, appHits=127, showAppHits=0, pcHits=340, showPcHits=2388, likes=1, shares=1, comments=4, approvalStatus=1, publishedTime=Tue Sep 08 00:51:22 CST 2020, publishedTimeString=2020-07-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Sep 08 00:18:54 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 03:35:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESMO共识会议建议：局部黑色素瘤的治疗.pdf)])
2020 ESMO共识会议建议：局部黑色素瘤的治疗.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1218963, encodeId=f946121896349, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:13 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883659, encodeId=412a883659be, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a15416656, createdName=稻草人129, createdTime=Tue Sep 08 16:45:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883493, encodeId=ebb38834935d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Tue Sep 08 07:51:55 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2022-05-12 ms5000001683434619

    赞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1218963, encodeId=f946121896349, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:13 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883659, encodeId=412a883659be, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a15416656, createdName=稻草人129, createdTime=Tue Sep 08 16:45:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883493, encodeId=ebb38834935d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Tue Sep 08 07:51:55 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2020-09-08 稻草人129

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1218963, encodeId=f946121896349, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4606479486, createdName=ms5000001683434619, createdTime=Thu May 12 08:53:13 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883659, encodeId=412a883659be, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35a15416656, createdName=稻草人129, createdTime=Tue Sep 08 16:45:28 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883493, encodeId=ebb38834935d, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200903/79d0f015e6084e5ca462828ca002414e/27d5d6b264cb4eeebf7092dc1fb8eae8.jpg, createdBy=22155415237, createdName=ms7000000139248197, createdTime=Tue Sep 08 07:51:55 CST 2020, time=2020-09-08, status=1, ipAttribution=)]
    2020-09-08 ms7000000139248197

    好

    0

相关指南

2020 英国国家指南：头颈部黏膜黑色素瘤

国外肿瘤科相关专家小组（统称） · 2020-08-20

2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）

欧洲皮肤病学论坛(EDF,European Dermatology Forum) · 2019-12-19

2019 欧洲多学科共识指南：黑色素瘤的诊断

欧洲皮肤病学论坛(EDF,European Dermatology Forum) · 2020-01-09

皮肤黑色素瘤的主要切除切缘，前哨淋巴结活检和完全淋巴结清扫：临床实践指南

暂未更新 · 2019-09-27

黑色素瘤诊疗规范（2018年版）

中华人民共和国国家卫生健康委员会 · 2018-12-13

中国黑色素瘤规范化病理诊断专家共识（2017年版）

中国肿瘤科相关专家小组（统称） · 2018-01-15

拓展阅读

2010 CCO建议 躯干或四肢皮肤黑色素瘤临床淋巴结阴性首发切除边缘和前哨淋巴结活检

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-01-01

（2010 BAD）英国皮肤黑色素瘤管理指南2010年更新版

英国皮肤科医师协会(BAD,British Association of Dermatologists) · 2010-08-01

中国黑色素瘤诊治指南2011版（修改版）

中国抗癌协会临床肿瘤学协作专业委员会(CSCO,Chinese Society of Clinical Oncology) · 2011-09-18

原发性皮肤黑色素瘤的治疗和管理的护理指南（AAD 2011）

美国皮肤病学会(AAD,American Academy of Dermatology) · 2011-11-01

2012 ESMO临床实践指南：黑色素瘤的诊断、治疗与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

2012 ASCO/SSO联合指南：黑色素瘤前哨淋巴结活检

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2012-07-09